{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-05",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "cfres_id": "184770",
      "product_res_number": "Z-0843-2021",
      "event_date_initiated": "2020-11-12",
      "event_date_created": "2021-01-11",
      "recall_status": "Open, Classified",
      "res_event_number": "86895",
      "product_code": "MDS",
      "k_numbers": [
        "K151236"
      ],
      "product_description": "CareLink Personal Software Therapy Management Software Tool for Diabetes\nCareLink System Therapy Management Software Tool for Diabetes\n\nSoftware Uploader versions:\n3.1.5.000\n3.1.2.000",
      "code_info": "CareLinkTM Personal (MMT-7333) using CareLink Uploader (ACC-7350) UDI (GTIN/UPN): 00763000424121  CareLinkTM system (MMT-7350) using CareLink Uploader (ACC-7350) UDI (GTIN/UPN): 00763000424138",
      "firm_fei_number": "3003166194",
      "recalling_firm": "Medtronic Inc.",
      "address_1": "18000 Devonshire St",
      "city": "Northridge",
      "state": "CA",
      "postal_code": "91325-1219",
      "additional_info_contact": "Pamela Reese\n818-576-3398",
      "reason_for_recall": "Incomplete basal rate information may be transmitted leading to a potential for inappropriate change in therapy.  During data upload, radio frequency (RF) interference can occur at any point from surrounding devices or equipment that may affect the data transfer between the insulin pump and the CareLink Personal or CareLink System Software.",
      "root_cause_description": "Device Design",
      "action": "On 11/19/2020, the firm sent an \"URGENT FIELD SAFETY NOTIFICATION\" Letter via email, fax, mail and/or phone to its U.S. Customer, and on 12/07/2020, the firm initiated O.U.S Notification using approved regional methods.  The Notification Letter informs customers that after the release of an updated uploader software version the following issues/scenarios may result:\n1. Some reports may be missing all programmed basal rates in the device. This may result in a blank value on the Device Settings report of the 24-hour basal total.\n2. Some reports may only display certain programmed basal rates and some basal rates in the device may be missing from the reports. This may result in a miscalculation on the Device Settings report of the 24-hour basal total.\n\nThe following reports may be affected by these issues include:  Device Settings, Daily Review/Daily Details, Weekly Review, and Sensor & Meter Overview.  These reports have been utilized to adjust therapy settings or to transfer settings from an old pump to a new pump.  If all of the following are true, it could lead to either over- or under-delivery of insulin which may result in low blood glucose (hypoglycemia, loss of consciousness), and/or high blood glucose (hyperglycemia):\na) adjustments were made to therapy settings or if therapy settings were transferred from one device to another, and\nb) these actions were taken based on a report generated using CareLink\" uploader version 3.1.5.000 that has missing or incomplete basal rates, and\nc) you are using Manual Mode\n\nThe Recalling Firm is instructing customers to:\n1. Install the new CareLink\" uploader version 3.1.6.000 available within the CareLink\" software to each computer where you upload devices. To confirm your current uploader version or to learn how to install the latest uploader, see the FAQ section at the end of this letter.\n2. If you have had insulin settings adjusted that may have been made based on an impacted CareLink\" report, review your settings",
      "product_quantity": "46,461 affected systems",
      "distribution_pattern": "U.S. Nationwide\n\nO.U.S. Worldwide\n\nRefer to Associated Documents and uploaded Consignee Lists/Spreadsheets.\n-Australia New Zealand\n-Canada\n-EMEA\n-Greater China\n-India\n-Japan\n-Latin America\n-South Korea\n-Southeast Asia\n-US",
      "openfda": {
        "pma_number": [
          "P050020",
          "P150029",
          "P120010",
          "P980022",
          "P150021",
          "P150019",
          "P160007",
          "P130007",
          "P050012",
          "P140015",
          "P120005"
        ],
        "registration_number": [
          "3010893867",
          "3004139819",
          "3007981285",
          "2954323",
          "2024024",
          "3013756811",
          "3006371704",
          "3009171251",
          "3002807314",
          "3014498598",
          "2030598",
          "2134850",
          "9710492",
          "2032227",
          "3042027705",
          "3009882464",
          "3007421145",
          "3007939342",
          "3007527549"
        ],
        "fei_number": [
          "3010893867",
          "3004139819",
          "3007981285",
          "2024024",
          "3013756811",
          "3006371704",
          "1000518731",
          "3003007876",
          "3004173703",
          "3002807314",
          "3006759904",
          "3014498598",
          "3042027705",
          "3003166194",
          "3009882464",
          "3002803444",
          "3003500908",
          "3007939342",
          "3007527549"
        ],
        "device_name": "Sensor, Glucose, Invasive",
        "medical_specialty_description": "Unknown",
        "regulation_number": "",
        "device_class": "3"
      }
    }
  ]
}